MX2007008417A - Forma de dosificacion para tratar desordenes gastrointestinales. - Google Patents

Forma de dosificacion para tratar desordenes gastrointestinales.

Info

Publication number
MX2007008417A
MX2007008417A MX2007008417A MX2007008417A MX2007008417A MX 2007008417 A MX2007008417 A MX 2007008417A MX 2007008417 A MX2007008417 A MX 2007008417A MX 2007008417 A MX2007008417 A MX 2007008417A MX 2007008417 A MX2007008417 A MX 2007008417A
Authority
MX
Mexico
Prior art keywords
proton pump
pump inhibitor
enteric coating
dosage form
gastrointestinal disorders
Prior art date
Application number
MX2007008417A
Other languages
English (en)
Inventor
John R Plachetka
Original Assignee
Pozen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pozen Inc filed Critical Pozen Inc
Priority claimed from PCT/US2006/000782 external-priority patent/WO2006076338A2/en
Publication of MX2007008417A publication Critical patent/MX2007008417A/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se dirige a formas de dosificacion de medicamentos que se pueden usar para tratar enfermedades caracterizadas por secrecion anormal de acidos gastricos. Las formas de dosificacion tienen un nucleo conteniendo un inhibidor de bomba de protones rodeado por un recubrimiento enterico o particulas multiples conteniendo inhibidor de bomba de protones, cada particula estando rodeada por un recubrimiento enterico. El recubrimiento enterico retrasa la liberacion del medicamento hasta que el pH que le rodea se ha elevado. Las tabletas tambien incluyen un recubrimiento exterior que contiene ya sea un inhibidor de bomba de protones o un bloqueador de H2. El recubrimiento exterior se disena para disolverse rapidamente en el estomago de un paciente.
MX2007008417A 2005-01-12 2006-01-11 Forma de dosificacion para tratar desordenes gastrointestinales. MX2007008417A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64313705P 2005-01-12 2005-01-12
PCT/US2006/000782 WO2006076338A2 (en) 2005-01-12 2006-01-11 Dosage form for treating gastrointestinal disorders

Publications (1)

Publication Number Publication Date
MX2007008417A true MX2007008417A (es) 2008-01-24

Family

ID=38462201

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007008417A MX2007008417A (es) 2005-01-12 2006-01-11 Forma de dosificacion para tratar desordenes gastrointestinales.

Country Status (4)

Country Link
EP (1) EP1841409A2 (es)
CN (1) CN101102750A (es)
EA (1) EA200701499A1 (es)
MX (1) MX2007008417A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103230593A (zh) * 2012-10-30 2013-08-07 辽宁亿灵科创生物医药科技有限公司 一种治疗胃肠疾病的药物组合物
CN103006611B (zh) * 2013-01-04 2014-06-25 青岛大学 一种奥美拉唑肠溶双层缓释片剂
CN103127026B (zh) * 2013-02-05 2017-02-15 悦康药业集团有限公司 一种奥美拉唑肠溶胶囊及其制备方法

Also Published As

Publication number Publication date
CN101102750A (zh) 2008-01-09
EP1841409A2 (en) 2007-10-10
EA200701499A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
WO2006076338A3 (en) Dosage form for treating gastrointestinal disorders
MX2011013467A (es) Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
MX2010010525A (es) Inhibidores de metaloproteasa de matriz basados en aril-sulfonamida.
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
MX2010001071A (es) Formas de dosificacion retentivas gastricas pulsatiles.
MX2007004987A (es) Nuevas formulaciones de tabletas de liberacion modificada para inhibidores de bomba de protones.
MX341212B (es) Inhibidor de bromodominio de benzodiazepina.
EP3311818A3 (en) Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
IL219857A0 (en) Mitotic kinesin inhibitors, pharmaceutical compositions comprising them, uses thereof in the manufacture of a medicament for the treatment of disease or disorder in a human or animal that can be treated by inhibiting mitosis
MX2011012122A (es) Derivados de tiofeno.
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
TN2009000444A1 (en) Combination therapy with a compound acting as a plateletadp receptor inhibitor
IN2014MN00139A (es)
MX2020004099A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
WO2008016887A3 (en) Methods and pharmaceutical compositions to treat gastric acid disorders
WO2009153665A3 (en) Inhibitors of the shiga toxins trafficking through the retrograde pathway
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
TW200628473A (en) Novel heterocycles
WO2008049984A3 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
EA201270071A1 (ru) Способ лечения пациента, нуждающегося в аспириновой терапии
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
WO2007117981A3 (en) Selective hydroxamate based mmp inhibitors
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
MX2007008417A (es) Forma de dosificacion para tratar desordenes gastrointestinales.
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid

Legal Events

Date Code Title Description
FA Abandonment or withdrawal